Chemical Structure
Chloroguanabenz . acetate [23113-55-5]
AG-MR-C0036
CAS Number23113-55-5
Product group Chemicals
Estimated Purity>95%
Molecular Weight265.5 . 60.1
Overview
- SupplierAdipoGen Life Sciences
- Product NameChloroguanabenz . acetate [23113-55-5]
- Delivery Days Customer10
- ADR Class6.1
- CAS Number23113-55-5
- CertificationResearch Use Only
- Estimated Purity>95%
- Hazard InformationDanger,Excepted quantity
- Molecular FormulaC8H7Cl3N4 . C2H4O2
- Molecular Weight265.5 . 60.1
- Scientific DescriptionAntiprion agent. Inhibitor of protein aggregation. Specifically reduces accumulation of a pathogenic fragment of Huntingtin in a transiently transfected cellular model of Huntingtons disease (HD). Tool for treating HD and other polyglutamine expansion associated diseases. - Chemical. CAS: 23113-55-5. Formula: C8H7Cl3N4 . C2H4O2. MW: 265.5 . 60.1. Antiprion agent. Inhibitor of protein aggregation. Specifically reduces accumulation of a pathogenic fragment of Huntingtin in a transiently transfected cellular model of Huntingtons disease (HD). Tool for treating HD and other polyglutamine expansion associated diseases.
- SMILESCC(=N)N\N=C\C1=C(Cl)C=CC(Cl)=C1Cl
- Storage Instruction-20°C,2°C to 8°C
- UN NumberUN 2811
- UNSPSC51202000
References
- Antihypertensive drug guanabenz is active in vivo against both yeast and mammalian prions: D. Tribouillard-Tanvier, et al.; PLoS One 3, e1981 (2008)
- Use of chlorine guanabenz derivatives for treating polyglutamine expansion associated diseases: A. Bertolotti & M. Blondel; Patent WO002008041133A2 (2008)
- Synthesis of conjugates of 6-aminophenanthridine and guanabenz, two structurally unrelated prion inhibitors, for the determination of their cellular targets by affinity chromatography: F. Gug, et al.; Bioconjug. Chem. 21, 279 (2010)